Home
>
US Stocks
>
Magenta Therapeutics Inc
Magenta Therapeutics Inc
MGTA

Magenta Therapeutics Inc (MGTA)

$6.50.46%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$6.46
Today Low/High$6.35 / $6.6
52 Week Low/High$5.89 / $14.2
Market Cap$379.52M

Company Details

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.
OrganisationMagenta Therapeutics Inc
HeadquatersCambridge, Massachusetts, US
Employees69
IndustryHealth Technology
CEOJason Gardner

Discover more

Frequently Asked Questions

What is Magenta Therapeutics Inc (MGTA) share price today?

Can Indians buy Magenta Therapeutics Inc (MGTA) shares?

How can I buy Magenta Therapeutics Inc (MGTA) shares from India?

Can Fractional shares of Magenta Therapeutics Inc (MGTA) be purchased?

What are the documents required to start investing in Magenta Therapeutics Inc (MGTA) stocks?

We are a SEBI registered investement advisor